首页|期刊导航|心脑血管病防治|载脂蛋白A1/载脂蛋白B比值对急性心肌梗死患者PCI后无复流的预测价值

载脂蛋白A1/载脂蛋白B比值对急性心肌梗死患者PCI后无复流的预测价值OA

Predictive value of apolipoprotein A1/apolipoprotein B ratio for no-reflow after percutaneous coronary intervention in patients with acute myocardial infarction

中文摘要英文摘要

目的 探究急性心肌梗死患者载脂蛋白(Apo)A1/ApoB比值对经皮冠状动脉介入治疗(PCI)后无复流的预测价值.方法 回顾性选取 2018 年 1 月至 2022 年 3 月在宁波大学附属人民医院就诊的急性心肌梗死患者 106 例纳入研究.采用心肌梗死溶栓治疗(TIMI)来评估复流情况,TIMI分级≤2 级为无复流组(29 例),TIMI分级>2 级为复流组(77 例).采用酶联免疫吸附法(ELISA)检测血清ApoA1、ApoB水平,并计算ApoA1/ApoB比值.采用Pearson法分析急性心肌梗死患者ApoA1、ApoB相关性.采用Logistic回归分析急性心肌梗死患者行PCI后无复流的影响因素.ApoA1、ApoB及其比值预测急性心肌梗死患者接受PCI后无复流的效能采用ROC曲线分析.结果 无复流组心肌肌钙蛋白I(t=7.450,P<0.05)、总胆固醇(t=5.226,P<0.05)、ApoB水平(t=8.987,P<0.05)高于复流组,ApoA1 水平(t=5.960,P<0.05)与ApoA1/ApoB比值(t=8.959,P<0.05)低于复流组.ApoA1 与ApoB水平呈负相关(r=-0.590,P<0.05).高水平的心肌肌钙蛋白I(OR=2.791,95%CI=1.502~5.185,P<0.05)、ApoB(OR=2.175,95%CI=1.051~4.501,P<0.05)是无复流的危险因素,高水平的ApoA1(OR=0.722,95%CI=0.565~0.922,P<0.05)、ApoA1/ApoB比值(OR=0.566,95%CI=0.459~0.698,P<0.05)是无复流的保护因素.血清ApoA1、ApoB水平、ApoA1/ApoB比值及三者联合预测急性心肌梗死患者接受PCI后无复流的AUC分别为 0.843、0.887、0.915、0.956.三者联合预测优于各自单独预测(Z=2.500、2.301、2.023,P<0.05).结论 ApoB、ApoA1 及ApoA1/ApoB比值是急性心肌梗死患者行PCI 后无复流的影响因素,ApoA1、ApoB水平及ApoA1/ApoB比值对于急性心肌梗死患者PCI术后无复流均具有预测价值,且联合预测的价值更高.

Objective To investigate the predictive value of the apolipoprotein(Apo)A1/ApoB for no-reflow after percutaneous coronary intervention(PCI)in patients with acute myocardial infarction(AMI).Methods A total of 106 AMI patients admitted to the Affiliated People's Hospital of Ningbo University from January 2018 to March 2022 were retrospectively selected for the study.The thrombolysis in myocardial infarction(TIMI)flow grade was used to assess coronary reperfusion,with TIMI grade≤2 as the no-reflow group(29 cases)and TIMI grade>2 as the reflow group(77 cases).Serum levels of ApoA1 and ApoB were measured using enzyme-linked immunosorbent assay(ELISA),and the ApoA1/ApoB ratio was calculated.Pearson correlation analysis was performed to evaluate the relationship between ApoA1 and ApoB in AMI patients.Logistic regression analysis was used to identify factors influencing no-reflow after PCI treatment in AMI patients.The predictive value of ApoA1,ApoB,and their ratio for no-reflow after PCI treatment in AMI patients was assessed using receiver operating characteristic(ROC)curve analysis.Results Compared with the reflow group,the no-reflow group had higher levels of cardiac troponin I(cTnI)(t=7.450,P<0.05),total cholesterol(t=5.226,P<0.05),and ApoB(t=8.987,P<0.05),and lower levels of ApoA1(t=5.960,P<0.05)and ApoA1/ApoB ratio(t=8.959,P<0.05).ApoA1 and ApoB levels were negatively correlated(r=-0.590,P<0.05).High levels of cTnI(OR=2.791,95%CI=1.502-5.185,P<0.05)and ApoB(OR=2.175,95%CI=1.051-4.501,P<0.05)were identified as risk factors for no-reflow,while high levels of ApoA1(OR=0.722,95%CI=0.565-0.922,P<0.05)and ApoA1/ApoB ratio(OR=0.566,95%CI=0.459-0.698,P<0.05)were protective factors.The areas under the curve(AUCs)for serum ApoA1,ApoB,ApoA1/ApoB ratio,and their combined prediction of no-reflow in AMI patients after PCI were 0.843,0.887,0.915,and 0.956,respectively.The combined prediction was superior to any individual prediction(Z=2.500,2.301,2.023;P<0.05).Conclusion ApoB,ApoA1 and ApoA1/ApoB ratio are influencing factors for no-reflow in AMI patients after PCI.Serum ApoA1,ApoB,and the ApoA1/ApoB ratio all have predictive value for no-reflow in AMI patients after PCI and their combined prediction possesses a higher value.

吴益波;张奇军;饶志高

315040 宁波,宁波大学附属人民医院心血管内科315040 宁波,宁波大学附属人民医院心血管内科315040 宁波,宁波大学附属人民医院肿瘤内科

载脂蛋白A1载脂蛋白B急性心肌梗死经皮冠状动脉介入治疗

Apolipoprotein A1Apolipoprotein BAcute myocardial infarctionPercutaneous coronary intervention

《心脑血管病防治》 2026 (2)

21-24,34,5

10.3969/j.issn.1009-816x.2026.02.005

评论